SEC Form 4 · accession 0001127602-15-033165
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred E Cohen
Director
Period of report
Nov 30, 2015
Accepted (ET)
Dec 3, 2015 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 30, 2015 | A | 824 | $10.61 | A | 104,669 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $8,750.